Current Edition


After its $7.6B buyout fell through, Sobi scores NICE backing for rare disease drug Aspaveli

After rare disease drugmaker Sobi reportedly had a buyout scuppered by pharma giant AstraZeneca, the company has picked up a win that stands to bolster …

Continue Reading →

InSciTe project that targets new way to take eye medicines enters clinical studies

 One of the projects of the Chemelot Institute for Science and Technology (InSciTe, The Netherlands) has been granted permission by the ‘Dutch Health and Youth …

Continue Reading →